📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-07 16:29
1 analysed today
FollowTelegram
1
Today
151,861
All-time analysed
43,535
Positive
6,743
Negative
92,746
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
6 announcements match the current filters (relevance ≥ 5).
Global Longlife Hospital Calls EGM to Ratify Name Change to Asahi Enterprise, Allocating ₹17.02 Cr
Global Longlife Hospital and Research Ltd has scheduled an Extra-Ordinary General Meeting (EGM) on October 30, 2026, to ratify the submission of a CA certificate for changing its name to Asahi Enterprise Limited. According to the certificate under SEBI LODR Regulation 45, the company has deployed ₹1,702.15 Lakhs (₹17.02 Cr), classified as cash and cash equivalents, into a new activity or project, representing 71.73% of total assets (₹2,372.98 Lakhs). This pivot comes alongside a change in its main business object as previous hospital operations shrunk to zero revenue in recent quarters.
Confidence: HIGH
What changedThe company has called an EGM to ratify compliance for rebranding itself as Asahi Enterprise Limited and altering its main business objects.
Why it mattersWith core healthcare revenues dropping to near zero and promoter holdings reducing from 55.1% to 22.9%, redeploying ₹17.02 Cr (over 70% of assets) into a new line of business signals a complete operational overhaul.
Investment in new activity: 1,702.15 LakhsTotal assets as on June 30, 2026: 2,372.98 LakhsShare of new activity in total assets: 71.73%Investment vs Market Cap: ~106%
📅 Short termShareholders will vote on the name change and regulatory ratification on October 30, 2026.
📈 Long termRepresents a complete strategic pivot away from existing hospital operations; long-term viability depends entirely on the operational execution of the undisclosed new business activity.
⚠ Risk flags
- Lack of technical verification: CA certificate states no independent validation was done on underlying software, algorithms, or AI models.
- Sharp drop in promoter holding from 55.1% in Sep 2025 to 22.88% in Mar 2026.
- Severe revenue drop in core operations, with TTM revenue at just ₹1 Cr.
Key Highlights
EGM scheduled on Friday, October 30, 2026, at 12:15 P.M. IST via VC/OAVM.
Special resolution to ratify the CA certificate for changing company name to Asahi Enterprise Limited.
Investment in new activity stands at ₹1,702.15 Lakhs, representing 71.73% of total assets of ₹2,372.98 Lakhs.
Investment in new activity exceeds the regulatory minimum threshold of 50% (₹1,186.49 Lakhs).
👀 What to Watch
Track shareholder approval during the EGM on October 30, 2026, and watch for subsequent detailed disclosures regarding the commercial nature, business plan, and revenue traction of the new activity.
Abhishek Ashvinbhai Kamdar HUF Acquires 5.09% Stake in Global Longlife Hospital
Abhishek Ashvinbhai Kamdar HUF has acquired a 5.09% stake in Global Longlife Hospital and Research Ltd via open market transactions on September 25, 2026. The acquisition involves 5,35,000 equity shares out of the total voting share capital of 1,05,00,000 shares. Prior to this transaction, the acquirer held zero shares in the company. This substantial acquisition occurs against a backdrop of declining promoter shareholding, which dropped to 22.88% by March 2026.
Confidence: HIGH
What changedAbhishek Ashvinbhai Kamdar HUF entered the company as a substantial public shareholder with a 5.09% stake.
Why it mattersA new investor crossing the 5% disclosure threshold alters public shareholding dynamics, notably as promoter holding has sharply declined from 55.1% to 22.88% in recent quarters.
Shares Acquired: 5,35,000Stake Acquired: 5.09%Pre-acquisition Holding: --Total Voting Shares: 1,05,00,000Date of Acquisition: 25/09/2026
📅 Short termMay trigger short-term trading liquidity given the micro-cap size (Rs 16 Cr market cap) and low free float.
📈 Long termLimited operational impact unless this substantial stake purchase leads to active engagement or management-level shifts.
⚠ Risk flags
- Steep drop in promoter stake to 22.88%
- Company is currently loss-making with negligible quarterly revenues
Key Highlights
Acquisition of 5,35,000 equity shares representing 5.09% voting capital
Pre-transaction holding was nil (0.00%)
Transaction conducted via open market on September 25, 2026
Total paid-up and voting equity capital remains 1,05,00,000 shares of Rs 10 each
👀 What to Watch
Monitor upcoming shareholding pattern filings to track whether the new non-promoter substantial shareholder builds an active stake or further changes company control.
Global Longlife Hospital Alters MOA to Add Agro, Textiles & Bullion Trading
Global Longlife Hospital and Research Ltd has received Ministry of Corporate Affairs (MCA) approval for Form MGT-14 to alter its Main Objects Clause effective August 25, 2026. The amendment expands the company's scope significantly beyond hospital operations into trading and processing of agricultural produce, food commodities, apparel, textiles, and bullion/precious metals. This pivot comes amid weak financials, with TTM revenue at Rs 1 Cr, net losses of Rs -2 Cr, and promoter holding declining to 22.88% in March 2026.
Confidence: HIGH
What changedMCA approved the alteration of the company's Main Objects Clause under the MOA to allow business activities in agriculture, textiles, and precious metals.
Why it mattersIndicates a potential major business model pivot away from struggling hospital operations where quarterly revenues have fallen to near zero.
Effective Date: August 25, 2026Market Cap: Rs 11 CrTTM Revenue: Rs 1 CrPromoter Holding: 22.88%
📅 Short termThe announcement clarifies regulatory clearance for new business lines, but near-term commercial impact remains speculative until operational plans are disclosed.
📈 Long termPivoting into unrelated, fragmented industries like agro and commodity trading carries substantial execution and governance risks for a microcap hospital entity.
⚠ Risk flags
- Complete business pivot risk into unrelated trading/agro sectors
- Sharp drop in promoter holding from 54.9% (Jun 2025) to 22.88% (Mar 2026)
- Subdued operating performance with negative TTM PAT of Rs -2 Cr
Key Highlights
MCA approval received for Form MGT-14 with effect from August 25, 2026
Main Objects expanded to cover food products, grains, spices, oilseeds, and agro produce
Scope broadened to include apparel, garments, textiles, and precious metals/bullion trading
Company market cap stands at Rs 11 Cr with TTM revenue of Rs 1 Cr
👀 What to Watch
Track subsequent corporate announcements to see whether concrete capital allocation, management changes, or operational rollouts accompany this planned diversification into non-healthcare lines.
6.88% Stake Sale by Promoter Dhruv Jani in Global Longlife Hospital
Dhruv Sureshkumar Jani, a member of the promoter group, sold 7,22,000 equity shares (6.88% stake) in the open market between August 10 and August 12, 2026. This transaction has effectively liquidated his position, reducing his holding from 6.89% to just 0.01%. This sale is significant given the company's micro-cap status (Rs 13 Cr) and the existing downward trend in total promoter holding, which dropped from 55.1% in September 2025 to 22.88% in March 2026. The company is currently struggling financially, reporting near-zero revenue and a net loss of Rs 2 Cr for the trailing twelve months.
Confidence: HIGH
What changedA member of the promoter group, Dhruv Jani, has sold nearly his entire 6.88% stake in the company through open market transactions.
Why it mattersLarge-scale promoter selling in a company with negative operating margins (-889.7%) and declining revenue suggests a lack of confidence in a turnaround or a potential shift in corporate control.
Shares Sold: 7,22,000Stake Sold: 6.88%Post-Sale Holding: 0.01%TTM Revenue: Rs 1 CrMarket Cap: Rs 13 Cr
📅 Short termThe open market sale of a 6.88% stake may create immediate supply pressure on the stock, which is already down 46.4% over the last 12 months.
📈 Long termThe structural outlook remains weak as the promoter group continues to dilute their stake while the business fails to generate meaningful revenue or profit.
⚠ Risk flags
- Significant promoter stake dilution
- Poor financial health (Negative PAT and OPM)
- Micro-cap liquidity risks
- Declining promoter holding trend
Key Highlights
Sale of 7,22,000 equity shares representing 6.88% of the total voting capital
Seller's residual holding reduced to 990 shares or 0.01% post-transaction
Transaction executed via open market between August 10, 2026, and August 12, 2026
Total equity share capital remains at 1,05,00,000 shares of Rs 10 each
Promoter group holding has seen a sharp decline from 55.1% in Sep 2025 to 22.88% in Mar 2026
👀 What to Watch
Investors should closely monitor the upcoming September 2026 shareholding pattern to see if other promoters are also exiting. The combination of near-zero revenue and significant promoter selling is a major red flag for a micro-cap entity.
9.52% Stake Sale by Promoter Dhruv Sureshkumar Jani via Open Market
Dhruv Sureshkumar Jani, a member of the promoter group, sold 10,00,000 equity shares representing a 9.52% stake in Global Longlife Hospital and Research Ltd. The transaction occurred in the open market between August 6 and August 7, 2026. This sale reduced the individual's holding from 16.41% to 6.89%. This follows a significant downward trend in total promoter holding, which fell from 55.1% in September 2025 to 22.88% by March 2026.
Confidence: HIGH
What changedA significant promoter group member liquidated nearly 60% of their personal holding in the company through open market sales.
Why it mattersLarge-scale promoter selling in a micro-cap company (Rs 14 Cr market cap) with negligible revenue (Rs 0.0 cr in Mar 2026) and negative margins is typically a sign of low confidence or liquidity requirements by the founders.
Shares Sold: 10,00,000Stake Sold (%): 9.52%Post-sale Holding: 6.89%Total Equity Capital: Rs 10,50,00,000TTM PAT: Rs -2 Cr
📅 Short termThe open market sale of nearly 10% of the company's capital over two days likely created significant selling pressure, which may continue if further liquidations occur.
📈 Long termThe structural outlook is weak as the promoter group has been consistently reducing its stake while the business remains loss-making with minimal operational revenue.
⚠ Risk flags
- High promoter selling
- Micro-cap liquidity risk
- Consistent net losses
- Negligible revenue generation
Key Highlights
Sale of 10,00,000 equity shares, equivalent to 9.52% of the company's total voting capital
Individual promoter group holding reduced from 17,22,990 shares (16.41%) to 7,22,990 shares (6.89%)
Disposal executed through open market transactions on August 6 and August 7, 2026
Company total equity share capital remains at 1,05,00,000 shares of Rs 10 each
👀 What to Watch
Investors should monitor the next quarterly shareholding pattern to see if the overall promoter group holding continues to decline below the 22.88% reported in March 2026, especially given the company's current loss-making status.
6.46% Stake Sale by Promoter Dhruv Jani in Global Longlife Hospital
Dhruv Sureshkumar Jani, a member of the promoter group, sold 6,78,000 equity shares of Global Longlife Hospital and Research Ltd between July 01 and July 30, 2026. This open-market transaction represents a 6.46% stake in the company, reducing the seller's individual holding from 22.87% to 16.41%. This sale occurs against a backdrop of deteriorating financials, with the company reporting a TTM loss of Rs 2 Cr and a significant decline in total promoter holding from 55.1% in September 2025 to 22.88% in March 2026.
Confidence: HIGH
What changedA member of the promoter group liquidated a 6.46% stake in the company through open market sales during July 2026.
Why it mattersSignificant promoter selling in a micro-cap company with stagnant revenue (Rs 1 Cr TTM) and consistent losses often signals a lack of confidence in a business turnaround or potential liquidity issues.
Shares Sold: 6,78,000Stake Sold (%): 6.46%Post-Sale Holding: 16.41%TTM Net Profit: Rs -2 CrMarket Cap: Rs 12 Cr
📅 Short termThe stock may face downward pressure due to the increased supply of shares in the open market and negative sentiment surrounding promoter divestment.
📈 Long termThe structural outlook is weak given the rapid reduction in promoter skin-in-the-game and the company's inability to generate meaningful revenue or profits.
⚠ Risk flags
- Significant promoter stake reduction
- Negative TTM PAT of Rs -2 Cr
- Extremely low revenue base of Rs 1 Cr
- Micro-cap liquidity risks
Key Highlights
Sale of 6,78,000 equity shares representing 6.46% of the total share capital
Seller's individual holding reduced from 22.87% to 16.41% post-transaction
Transactions executed via open market between July 01, 2026, and July 30, 2026
Company market capitalization remains low at approximately Rs 12 Cr
👀 What to Watch
Investors should monitor the upcoming quarterly shareholding pattern to confirm the total promoter group holding, which has been in a sharp downward trend. The combination of promoter exits and negative operating margins (-889.7%) warrants extreme caution.
